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Abstract 
Fat soluble vitamin K is an essential component of the blood clotting 
process. Menaquinones are the naturally occurring form of vitamin K 
produced by bacteria. Lipid extracts were made from three bacteria originally 
isolated from the human neonatal gut and identified as Enterobacter 
agglomerans, Serratia marcescens and Enterococcus faecium. Following 
preparative TLC the lipid extracts were subjected to LC-MS analysis. Peak 
analysis of the LC MS data showed that the three bacteria produce various 
forms of menaquinone. 
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1. Introduction 
 
Vitamin K is a generic term for a family of fat soluble vitamins. Two of 
the naturally occurring quinine forms are: phylloquinone (vitamin K1 or 2-
methyl-3-eicosa-2’-ene-1,4-naphthoquinone) which is obtained from plants 
and menaquinone (vitamin K2 or 2-methyl-3-multiprenyl-1,4-naphthoquinone), 
which is produced by certain bacteria during anaerobic respiration(1,2) 
Menaquinone variants are differentiated based on the number of isoprene-5-
carbon prenyl units on their side chains. Chain length varies from 2-15 
isoprene units (3). The variations in the structure of the menaquinones 
produced by bacteria have been used in bacterial classification (4). Several 
bacteria that have been isolated from the human intestine have previously 
been identified as producing menaquinones of various chain lengths and it is 
thought that these bacteria contribute to the vitamin K requirements of the 
human body (5). This paper discusses the identification of three previously 
unreported menaquinone producing bacteria isolated from faecal samples of 
neonates. 
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2. Materials and Methods 
 
 2.1 Cultures and Cultivation 
 
Cultures were isolated from faecal samples obtained from neonates 
aged between birth and 6 weeks old in a study previously carried out within 
our laboratory (6). The isolates were identified using selective media, Gram 
stains and API tests. Purified cultures were grown in 1 litre Durans containing 
tryptone soy broth powder (Lab M) dissolved in deionised water with haemin 
(10mg) and cysteine (0.05%w/v) (3).  The cultures were incubated 
anaerobically at 37oC for 72 hours. Cultures were checked for purity using 
Grams stains, selective and non-selective agar. The bacterial pellets were 
harvested in a Sorvall RC-5B centrifuge at 16,266g for 10 minutes at 4oC. The 
pellet was washed 3 times in 20ml volumes of 0.01M sterile phosphate 
buffered saline (PBS) and centrifuged again under the same conditions. 
Menaquinone 4 standard was purchased from Sigma, UK. 
 
 2.2 Extraction, Purification and Analysis of Menaquinones 
 
Extraction of suspect menaquinones from the wet bacterial pellets was 
carried out using the modified Bligh and Dyer method (7) developed by 
Hammond et al. (8), which involves the extraction of total lipid content. 
Menaquinone 4, currently the only commercially available menaquinone, was 
used as a standard as menaquinones of different side chain lengths migrate 
similar distances on thin layer chromatographic (TLC) plates (9). The 
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extracted menaquinones were then purified using the procedure as described 
by Fernandez et al. (9), on preparative silica gel GF254 prep TLC plates. The 
suspect menaquinones were viewed under a UV light box emitting light at 
254nm. Bands from the lipid extracts of the bacteria that were in line with the 
menaquinone 4 standard were removed and dissolved in 
dichloromethane:methanol::30:70, as was the menaquinone 4 standard, and 
all were subsequently analysed by mass spectrometry. Liquid 
chromatography-Mass spectrometrometry (LC-MS) analysis was carried out 
using a Bruker Daltronics Esquire liquid chromatography ion trap mass 
spectrometer with a Synergi Hydro C18 reverse phase (4.6mm X 250mm) 
HPLC column (00G-4375-E0) supplied by Phenomenex of Cheshire, UK 
using the conditions described in Table 1.  
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3. Results  
 
Previous studies have shown that menaquinones of differing side chain 
length give similar Rf values following TLC analysis (9) Therefore lipids 
extracts with bands which co-migrated with the menaquinone 4 standard 
(unpublished results) were subjected to further analysis to determine the 
exact menaquinone form produced by the respective bacteria being studied. 
 
The LC-MS data obtained for the standard menaquinone 4 are 
presented in Figure 1. Peak X, indicated in the total ion count shown in Figure 
1(a) was further analysed yielding the three significant peaks shown in Figure 
1(b). The molecular weights of the three peaks in Figure 1(b) correlated to the 
molecular weights of the protonated (mass = 445.3), sodiated (mass = 467.4) 
and potassiated (mass = 483.1) forms of menaquinone 4.  
 
 
LC-MS analysis of the extract from Enterobacter agglomerans  (Figure 
2a – peak A ) showed molecular weight bands at 717.5 (protonated), 739.7 
(sodiated) and 755.5 (potassiated) (Figure 2b) correlating to the expected 
molecular weight for Menaquinone 8 analogues. The sodiated analogue of 
Menaquinone 8 forms the base peak analogue as was detected for the 
Menaquinone 4 standard (Figure 1b).  
 
In addition to E.agglomerans, an isolate of  Serratia marcescens was 
also found to produce menaquinone 8 (Fig. 3a). As with the analysis of 
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E.agglomerans, the mass spectrometric analysis showed molecular weights 
corresponding to the protonated, sodiated and potassiated forms and the 
base peak as with the other bacterial extracts was the sodiated form of 
menaquinone 8 (Figure 3b). 
 
The peak detected for Enterococcus faecium TLC lipid extract (Figure 
4a – Peak C), although of weak intensity, gave sufficient signal to allow for 
identification as menaquinone 7. As with the analysis for the previous strains, 
the protonated, sodiated and potassiated forms of menaquinone were 
detected, with the sodiated analogue forming the base peak.  
 
 
4. Discussion 
 
The LC-MS results presented in this paper for the three bacterial 
strains E.agglomerans, S. marcescens  and E. faecium show peaks 
correlating with sodiated, protonated and hydrogenated derivatives of the 
menaquinones. Molecules of sodium, potassium and hydrogen are abundant 
in the environment and in this experiment they could be sourced from the 
glass vials used to store the samples. Ion contaminants have been reported 
previously to form apparently stable complexes with the menaquinones during 
electro-spray ionisation (10). The sodium, which forms the base peak 
analogue, is most likely forming weak covalent bonds with the oxygen on the 
ring structures of the menaquinones, as are the hydrogen and potassium.  
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This previously unreported identification of the strains E.agglomerans, 
S.marcescens and E.faecium as menaquinone producers will in the first 
instance contribute to aiding in their microbiological classification (11). In 
addition, the sourcing of these additional vitamin K producing strains from the 
neonatal gut flora show their potential as bacteria which could contribute in 
the neonate to the overall requirements of the vitamin K, an essential vitamin 
in the human blood clotting process (1). In the study presented here, the 
newly identified vitamin K producing strains together with several other 
previously reported vitamin K producing strains (Bacteroides ovatus, 
Citerobacter freundii, Enterococcus faecalis, Escherichia coli, Prevotella 
buccae, Staphylococcus capitis, Staphylococcus epidermidis, Staphylococcus 
haemolyticus and Staphylococcus warneri) were all isolated in infants of less 
than six weeks of age (unpublished results). Further studies would be 
required to confirm if the bacteria listed above are contributing significantly to 
the overall vitamin K requirement of the newborn infant at this age which 
could have implications in relation to the duration of hospital regimes for oral 
administration of vitamin K (12,13) as a prophylactic treatment for the 
prevention of haemorrhagic disease of the newborn (14). 
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Table 1. Conditions Used for Monitoring of Menaquinones on the Bruker 
  Esquire-LC Ion Trap LC/MS. 
 
HPLC System Bruker Esquire-LC Ion Trap LC/MS 
Column 
Synergi Hydro Reverse Phase C18 Column 
(250x4.6mm) 
Detector Ion Trap 
Mobile Phase Dichloromethane:Methanol (30:70) 
Monitored 
Wavelength 
270nm 
Flow Rate 0.3 and 0.4mls/min 
Sample Size 
Loaded 
Various 
Scan Begin 50.00 m/z 
Scan End 2200.00 m/z 
Ion Polarity Positive 
Ion Source Type Electro Spray Ionisation 
Sample Run Time 45-60 minutes 
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Figure 1 Mass spectrometric analysis of menaquinone standard using the 
conditions as listed in Table 1. 
(a) Total ion count of a directly injected menaquinone 4 standard 
(6µg/ml).  
(b) Mass spectrometric analysis of peak X (figure 1a) detected at 
13.8 minutes. 
 
 
 
 
 
 
 
 
 
(a) 
(b) 
[M+H] + 
[M+Na] + 
[M+K] + 
Peak X 
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Figure 2 Mass spectrometric analysis of  Enterobacter agglomerans extract 
carried out under the conditions listed in Table 1 
 (a) Extrapolated ion count for a TLC extract prepared from an 
Enterobacter agglomerans extract. 
(b) Mass spectrometric analysis of peak A detected at a retention 
time of 30 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(b) [M+H] + 
Peak A 
[M+Na] + 
[M+K] + 
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Figure 3 Mass spectrometric analysis of a Serratia marcescens extract 
carried out using the conditions as described in Table 1. 
(a) Extrapolated ion count for a TLC extract of Serratia 
marcescens extract. 
(b) Mass spectrometric analysis of peak B detected at a retention 
time of 30.6 minutes. 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(b) [M+H] + 
Peak B 
[M+Na] + [M+K] + 
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Figure 4 Mass spectrometric analysis of a Enterococcus faecium TLC 
extract analysed using the conditions as listed in Table 1. 
(a) Extrapolated ion count for individual peaks and total ion 
counts for a TLC extract obtained from an Enterococcus faecium. 
(b) Mass spectrometric analysis of the Peak C detected at a 
retention time of 31.6 minutes. 
 
 
 
 
[M+H] + 
[M+Na] + [M+K] + 
(a) 
(b) 
Peak C 
